90 related articles for article (PubMed ID: 8920785)
1. CA 125 as an indicator of pleural metastases in breast cancer patients.
Krämer S; Raff U; Jäger W; Lang N
Anticancer Res; 1996; 16(5B):3165-8. PubMed ID: 8920785
[TBL] [Abstract][Full Text] [Related]
2. CA 125 is an indicator for pleural metastases in breast cancer.
Krämer S; Jäger W; Lang N
Anticancer Res; 1997; 17(4B):2967-70. PubMed ID: 9329577
[TBL] [Abstract][Full Text] [Related]
3. Is an increase in CA 125 in breast cancer patients an indicator of pleural metastases?
Jäger W; Kissing A; Cilaci S; Melsheimer R; Lang N
Br J Cancer; 1994 Sep; 70(3):493-5. PubMed ID: 8080736
[TBL] [Abstract][Full Text] [Related]
4. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
5. Serum HER-2 extracellular domain (ECD) before the first metastasis in 128 breast cancer patients.
Pichon MF; Hacene K; Guepratte S; Neumann R
Clin Lab; 2004; 50(3-4):163-70. PubMed ID: 15074470
[TBL] [Abstract][Full Text] [Related]
6. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C
Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277
[TBL] [Abstract][Full Text] [Related]
7. [Pleuropulmonary metastases of female cancers].
Lemarié E; Milleron B
Rev Pneumol Clin; 1999 Oct; 55(5):271-9. PubMed ID: 10637893
[TBL] [Abstract][Full Text] [Related]
8. High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions.
Bielsa S; Esquerda A; Salud A; Montes A; Arellano E; Rodríguez-Panadero F; Porcel JM
Eur J Intern Med; 2009 Jul; 20(4):383-6. PubMed ID: 19524179
[TBL] [Abstract][Full Text] [Related]
9. CA 125 measurement in the follow-up of breast cancer patients.
Böhmer C; Jäger W; Lang N
Anticancer Res; 1997; 17(4B):3099-100. PubMed ID: 9329610
[TBL] [Abstract][Full Text] [Related]
10. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies.
Karapanagiotou EM; Pelekanou E; Charpidou A; Tsaganos T; Anagnostou V; Plachouras D; Giamarellos-Bourboulis EJ; Syrigos KN
Anticancer Res; 2008; 28(2B):1411-5. PubMed ID: 18505088
[TBL] [Abstract][Full Text] [Related]
11. [A case of lung and pleural metastases from breast cancer responding to toremifene].
Inoue K; Tabei T; Kusawake T; Sugamata N; Suemasu K; Higashi Y; Kurosumi M
Gan To Kagaku Ryoho; 2001 Feb; 28(2):221-4. PubMed ID: 11242650
[TBL] [Abstract][Full Text] [Related]
12. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
[TBL] [Abstract][Full Text] [Related]
13. Importance of serum prolactin determination in metastatic breast cancer patients.
Mujagić Z; Mujagić H
Croat Med J; 2004 Apr; 45(2):176-80. PubMed ID: 15103755
[TBL] [Abstract][Full Text] [Related]
14. Circulating hormone levels in breast cancer patients. correlation with serum tumor markers and the clinical and biological features of the tumors.
Hernández L; Nuñez-Villarl MJ; Martínez-Arribas F; Pollán M; Schneider J
Anticancer Res; 2005; 25(1B):451-4. PubMed ID: 15816610
[TBL] [Abstract][Full Text] [Related]
15. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
[TBL] [Abstract][Full Text] [Related]
16. Total procollagen type 1 amino-terminal propeptide (total P1NP) as a bone metastasis marker in gynecological carcinomas.
Oremek G; Sauer-Eppel H; Klepzig M
Anticancer Res; 2007; 27(4A):1961-2. PubMed ID: 17649805
[TBL] [Abstract][Full Text] [Related]
17. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study.
Topalak O; Saygili U; Soyturk M; Karaca N; Batur Y; Uslu T; Erten O
Gynecol Oncol; 2002 Apr; 85(1):108-13. PubMed ID: 11925128
[TBL] [Abstract][Full Text] [Related]
18. New approaches in the diagnostic procedure of malignant pleural effusions.
Terracciano D; Di Carlo A; Papa P; Cicalese M; Maietta P; Cecere C; Mariano A; Macchia V
Oncol Rep; 2004 Jul; 12(1):79-83. PubMed ID: 15201963
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
Li CS; Cheng BC; Ge W; Gao JF
Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status].
Bensouda Y; André F; Boulet T; Al-Ghuzlan A; Conforti R; Troalen F; Bourgier C; Errihani H; Spielmann M; Delaloge S
Bull Cancer; 2009 Oct; 96(10):923-8. PubMed ID: 19696005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
